Clinical Trial Detail

NCT ID NCT02799095
Title A Study of the Effects of ALKS 4230 on Subjects With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Alkermes, Inc.
Indications

ovarian cancer

Advanced Solid Tumor

renal cell carcinoma

melanoma

Therapies

ALKS 4230

Age Groups: adult

No variant requirements are available.